Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 23:45:25 GMT 2025
by
admin
on
Mon Mar 31 23:45:25 GMT 2025
|
| Protein Type | MONOCLONAL ANTIBODY |
| Protein Sub Type | TOXIN CONJUGATE |
| Sequence Origin | HUMANIZED MOUSE |
| Sequence Type | COMPLETE |
| Record UNII |
WE1X5A83B9
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
518016
Created by
admin on Mon Mar 31 23:45:25 GMT 2025 , Edited by admin on Mon Mar 31 23:45:25 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000177044
Created by
admin on Mon Mar 31 23:45:25 GMT 2025 , Edited by admin on Mon Mar 31 23:45:25 GMT 2025
|
PRIMARY | |||
|
10238
Created by
admin on Mon Mar 31 23:45:25 GMT 2025 , Edited by admin on Mon Mar 31 23:45:25 GMT 2025
|
PRIMARY | |||
|
1607824-64-5
Created by
admin on Mon Mar 31 23:45:25 GMT 2025 , Edited by admin on Mon Mar 31 23:45:25 GMT 2025
|
PRIMARY | |||
|
DB15453
Created by
admin on Mon Mar 31 23:45:25 GMT 2025 , Edited by admin on Mon Mar 31 23:45:25 GMT 2025
|
PRIMARY | |||
|
C100101
Created by
admin on Mon Mar 31 23:45:25 GMT 2025 , Edited by admin on Mon Mar 31 23:45:25 GMT 2025
|
PRIMARY | |||
|
WE1X5A83B9
Created by
admin on Mon Mar 31 23:45:25 GMT 2025 , Edited by admin on Mon Mar 31 23:45:25 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_95 |
| 1_142 | 1_198 |
| 1_259 | 1_319 |
| 1_365 | 1_423 |
| 2_22 | 2_95 |
| 2_142 | 2_198 |
| 2_259 | 2_319 |
| 2_365 | 2_423 |
| 1_218 | 3_214 |
| 2_218 | 4_214 |
| 1_224 | 2_224 |
| 1_227 | 2_227 |
| 3_23 | 3_88 |
| 3_134 | 3_194 |
| 4_23 | 4_88 |
| 4_134 | 4_194 |
| Glycosylation Type | HUMAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_295 |
| N | 2_295 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET->CONJUGATED TOXIN |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO ACID SUBSTITUTION | K |
Amount:
|
LYSINE-EMTANSINE | 6E9CC1P9UA |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:SEQUENCE(CALCULATED) | CHEMICAL |
|